Together, these data suggest that the CTLA-4|CD80/CD86 immune checkpoint is dysregulated similarly to the PD-1|PD-L1 checkpoint in murine and human ADPKD and that both checkpoints likely impact the function of distinct cell subpopulations. Here, CD86 is linked to autosomal dominant polycystic kidney disease.